Reisa Sperling

767 total citations
20 papers, 401 citations indexed

About

Reisa Sperling is a scholar working on Physiology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Reisa Sperling has authored 20 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 8 papers in Psychiatry and Mental health and 5 papers in Cognitive Neuroscience. Recurrent topics in Reisa Sperling's work include Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (7 papers) and Memory and Neural Mechanisms (3 papers). Reisa Sperling is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (7 papers) and Memory and Neural Mechanisms (3 papers). Reisa Sperling collaborates with scholars based in United States, United Kingdom and Netherlands. Reisa Sperling's co-authors include Erin Rand‐Giovannetti, Marilyn Albert, Daniel L. Schacter, Russell A. Poldrack, Elizabeth F. Chua, Keith A. Johnson, Sharon K. Inouye, Michael A. Fearing, David C. Alsop and Tamara G. Fong and has published in prestigious journals such as NeuroImage, Biological Psychiatry and The Journals of Gerontology Series A.

In The Last Decade

Reisa Sperling

14 papers receiving 392 citations

Peers

Reisa Sperling

PMH

CMN

PHYSI

CCICM

Andreas Ranft Germany

Hanqiu Li China

Tammy D. Kim South Korea

Zaid Ghazala Canada

Jennifer Cromer United States

L.S. Prichep United States

Leyla Loued‐Khenissi Switzerland

Viviane S. Hambrecht‐Wiedbusch United States

Vyoma D. Shah United States

Andreas Ranft Germany

Reisa Sperling

270 ×0.9

30 ×0.3

PMH

115 ×2.0

CMN

25 ×0.5

PHYSI

17 ×0.4

CCICM

Citations per year, relative to Reisa Sperling Reisa Sperling (= 1×) peers Andreas Ranft

Countries citing papers authored by Reisa Sperling

Since Specialization

Citations

This map shows the geographic impact of Reisa Sperling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reisa Sperling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reisa Sperling more than expected).

Fields of papers citing papers by Reisa Sperling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reisa Sperling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reisa Sperling. The network helps show where Reisa Sperling may publish in the future.

Co-authorship network of co-authors of Reisa Sperling

This figure shows the co-authorship network connecting the top 25 collaborators of Reisa Sperling. A scholar is included among the top collaborators of Reisa Sperling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reisa Sperling. Reisa Sperling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore, Gregory J., Niranjan Bose, Husseini K. Manji, Eric M. Reiman, & Reisa Sperling. (2025). Artificial intelligence and the acceleration of Alzheimer’s research - From promise to practice. The Journal of Prevention of Alzheimer s Disease. 13(1). 100421–100421.

Angioni, Davide, Lefkos Middleton, Randall J. Bateman, et al.. (2025). Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force. The Journal of Prevention of Alzheimer s Disease. 12(6). 100163–100163. 2 indexed citations

Ezzati, Ali, Richard Lipton, Reisa Sperling, et al.. (2025). Assessing Stages of Objective Memory Impairment and neuroimaging as risk factors of incident cognitive impairment. Journal of the International Neuropsychological Society. 31(7-8). 490–498.

Sperling, Reisa, Keith A. Johnson, Shobha Dhadda, et al.. (2025). Long‐term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open‐label extension study. Alzheimer s & Dementia. 21(12). e70905–e70905.

Jutten, Roos J., Jessie Fanglu Fu, Colin Birkenbihl, et al.. (2025). The Mobile Toolbox for remote, self‐administered cognitive assessment in older adults: associations with in‐clinic cognitive testing and Alzheimer's disease biomarkers. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(3). e70160–e70160.

Raman, Rema, Oliver Langford, Joel B. Braunstein, et al.. (2025). Racial and ethnic differences in plasma p‐tau217 ratio biomarker eligibility rates in a preclinical AD trial with lecanemab. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(3). e70164–e70164.

Aisen, Paul, Randall J. Bateman, Damian C. Crowther, et al.. (2024). The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence. Alzheimer s & Dementia. 21(1). e14342–e14342. 9 indexed citations

Boxer, Adam L., Reisa Sperling, Paul Aisen, et al.. (2024). The Alzheimer’s Tau Platform (ATP): a Phase 2, combination amyloid and tau therapy clinical trial for early AD. Alzheimer s & Dementia. 20(S6).

Raman, Rema, Michael Donohue, Karin Ernström, et al.. (2024). Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial. The Journal of Prevention of Alzheimer s Disease. 11(4). 874–880. 2 indexed citations

10.

Jacobs, Heidi I.L., J. Alex Becker, Kenneth K. Kwong, et al.. (2022). High-Resolution Structural Brainstem Nuclei: Locus Coeruleus Integrity as Potential Biomarker of Alzheimer’s Disease-Related Phenotypes. Biological Psychiatry. 91(9). S31–S31. 1 indexed citations

11.

Vannini, Patrizia, Federico d’Oleire Uquillas, Heidi I.L. Jacobs, et al.. (2019). Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults. NeuroImage Clinical. 24. 102097–102097. 11 indexed citations

12.

Sperling, Reisa, James J. Cummings, Michael Donohue, & Paul Aisen. (2016). GLOBAL ALZHEIMER’S PLATFORM TRIAL READY COHORTS FOR THE PREVENTION OF ALZHEIMER’S DEMENTIA. The Journal of Prevention of Alzheimer s Disease. 3(4). 1–3. 7 indexed citations

13.

Munro, Catherine E., Vaishnavi Rao, Alexander Dagley, et al.. (2015). Hippocampal Volume and Cardiovascular Risk Using the QRISK2 Prediction Tool in Cognitively Normal Elderly. American Journal of Geriatric Psychiatry. 23(3). S96–S97. 1 indexed citations

14.

Sperling, Reisa. (2012). To Sleep, Perchance to Delay Dementia. Archives of Neurology. 69(1). 118–118. 7 indexed citations

15.

Quiroz, Yakeel T., Chantal E. Stern, Eric M. Reiman, et al.. (2011). P1‐338: Cortical signature of Alzheimer's disease‐related thinning in presymptomatic presenilin‐1 mutation carriers. Alzheimer s & Dementia. 7(4S_Part_6). 1 indexed citations

16.

Sperling, Reisa & Keith A. Johnson. (2010). Pro: Can biomarkers be gold standards in Alzheimer's disease?. Alzheimer s Research & Therapy. 2(3). 17–17. 9 indexed citations

17.

Rentz, Dorene M., Erin K. Moran, J. Alex Becker, et al.. (2007). Intelligence quotient–adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. Journal of the International Neuropsychological Society. 13(5). 821–831. 12 indexed citations

18.

Alsop, David C., Michael A. Fearing, Keith A. Johnson, et al.. (2006). Review Article: The Role of Neuroimaging in Elucidating Delirium Pathophysiology. The Journals of Gerontology Series A. 61(12). 1287–1293. 45 indexed citations

19.

Sperling, Reisa, Elizabeth F. Chua, Erin Rand‐Giovannetti, et al.. (2003). Putting names to faces:. NeuroImage. 20(2). 1400–1410. 293 indexed citations

20.

Sperling, Reisa, Doug Greve, Anders M. Dale, et al.. (2001). Effects of lorazepam and scopolamine on encoding face-name associations: A pharmacologic fMRI trial. NeuroImage. 13(6). 743–743. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact